“…Antipeptide monoclonal antibodies against various segments of CT have been used in several types of studies, including some directed at vaccine development. Peptideantibody interactions were studied by nuclear magnetic resonance methods (7,8,172), which defined contact interactions between antibodies and a highly immunogenic peptide, CTB-3 (143), corresponding to residues CTB:50 through C`TB:64 in the holotoxin. Aromatic amino acids of two of the elicited antibodies (TE32 and TE33) were found to interact with Val, Pro, Gly, Gln, His, and Asp in the peptide, homologous to CTB residues 50, 53, 54, 56, 57, and 58, respectively, all of which are part of an exposed flexible loop near the binding pocket of LT (255).…”